 Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick Foti, LLC KSF are investigating the proposed sale of Cellular Biomedicine Group, Inc. CBMG or the Company NasdaqGS: CBMG to a newly-formed entity consisting of CBMGs CEO Tony Liu, certain member of the Companys management, and a consortium of stockholders and equity investors. Under the terms of the proposed transaction, shareholders of CBMG will receive only 19.75 in cash for each share of CBMG they own. KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether the consideration undervalues the Company. 